Author information from the last article
Kardiologisk avdeling
Oslo universitetssykehus, Rikshospitalet
og
Institutt for klinisk medisin
Universitetet i Oslo
Forfatterbidrag: utarbeiding/revisjon av manuset og godkjenning av innsendte manusversjon.
Lars Gullestad er dr.med. og professor emeritus.
Articles by Lars Gullestad
Chronic thromboembolic pulmonary hypertension
- John-Peder Escobar Kvitting,
- Håvard Ravnestad,
- Rune Andersen,
- Eyvind Gjønnæss,
- Natasha Moe,
- Sigurd Birkeland,
- Morten Svalebjørg,
- Per Snorre Lingaas,
- Einar Gude,
- Lars Gullestad,
- Kaspar Broch,
- Arne K. Andreassen
26.03.2025:
Chronic thromboembolic pulmonary hypertension is a rare complication of pulmonary embolism and entails high morbidity and mortality. The gold standard for treatment is pulmonary endarterectomy, which improves haemodynamics and exercise capacity, and is potentially curative. Alternative options for...
New international recommendations for type 2 diabetes – consequences for treatment practice in Norway?
- Kåre I. Birkeland,
- Sondre Meling,
- Ingvild Vatten Alsnes,
- Emelie Svensson,
- Lars Gullestad,
- Trond G. Jenssen
20.02.2023:
New international recommendations for the use of anti-hyperglycaemic drugs in patients with type 2 diabetes are at odds with current practice in Norway and the Norwegian Directorate of Health's national clinical guidelines. New knowledge indicates that changes are needed in the traditional treatment...
Myocardial fibrosis
- Torvald Espeland,
- Ida Gjervold Lunde,
- Brage H. Amundsen,
- Lars Gullestad,
- Svend Aakhus
12.10.2018:
Myocardial fibrosis arises when the heart's fibroblasts produce collagenous scar tissue. This process may primarily be reparative, but over time often has negative consequences for the patient in the form of function impairment, morbidity and mortality. Cardiovascular disease is still the dominant...
The follow-up after myocardial infarction – is it good enough?
- John Munkhaugen,
- Kari Peersen,
- Elise Sverre,
- Erik Gjertsen,
- Lars Gullestad,
- Toril Dammen,
- Einar Husebye,
- Jan Erik Otterstad
05.03.2018:
The majority of Norwegian coronary patients fail to change their lifestyle behaviour and miss the recommended treatment targets for cholesterol and blood pressure after discharge from hospital. Coronary heart disease is the single most important cause of death in the world, and annually more than 13...